Scientific poster - Comparing CSF and plasma LUMIPULSE® Alzheimer’s Disease biomarker analysis to amyloid-β PET imaging
Mar 16, 2022
Poster presented on March 16, 2022 at the AD/PD™ 2022
Amyloid pathology-confirmed diagnosis of Alzheimer’s Disease has been an increasing area of focus. Assistance of diagnosis using amyloid PET imaging or cerebrospinal fluid biomarkers has been challenging to implement in clinical care due to cost, availability, and/or invasiveness of sampling. These hurdles can be circumvented by the assessment of biomarkers in the more easily accessible plasma.
The aim of this study was to evaluate a plasma pTau biomarker as a tool for predicting amyloid pathology.
Related articles
Jan 4, 2023
Jan 4, 2023
Oct 10, 2022
Sep 20, 2022
Sep 20, 2022
Sep 20, 2022
Jun 13, 2022
May 18, 2022
Jan 31, 2022
Jan 10, 2022
Jan 7, 2022
Dec 16, 2021
Dec 16, 2021
Nov 19, 2021
Nov 18, 2021
Nov 18, 2021
Oct 29, 2021
Sep 21, 2021
Sep 20, 2021
Jun 23, 2021
Mar 16, 2020
Jan 20, 2020
Jan 9, 2020
Nov 22, 2019
Sep 30, 2019